Separate names with a comma.
Novartis is wagering high on gene therapy with its proposed acquisit ion of AveXis Inc. valued at $8.7 billion. The high-premium deal is expected...
All good things come to an end — and that includes Pfizer’s run with its blockbuster drug Viagra. The drugmaker’s little blue pill did help many...
Pfizer (PFE) has been contemplating on selling its consumer healthcare division for some time, and it had found two bidders - British...
It’s no big secret that investment in biotech stocks can offer great returns for investors, and at the same time, they can do some serious damage...
The latest study on the data retrieved from a few international organizations looked at the healthcare expenditures and performance outcome...
There is a lot to look forward to as Mylan reports earnings aftermarket today. The stock has been up 9.65% since it reported last quarter results....
If you ask Sansa Stark from HBO’s Game of Thrones, she’ll tell you the best way to go is to team up with someone strong or risk getting killed....
http://alph.st/b9cac1fc UnitedHealth's profits more than doubled in the fourth quarter to $3.61Bil due to tax benefits. $UNH also crossed $200Bil...
Revenue and profit down 4% each; US was negatively impacted by hurricanes, while other regions posted positive results. Better performance...
Technology continues penetrating the healthcare sphere, providing physicians with comprehensive solutions able to improve patient care....
Alexion's Soliris (eculizumab) product sales up 4% to $756 mil during the September quarter. Hope the FDA approval for Soliris for Myasthenia...
Amidst concern over an emerging competition for its da Vinci Surgical Systems, Intuitive Surgical posted its 3Q17 results where revenue increased...
Danaher has successfully transformed itself into a healthcare company with broader presence in the healthcare and dental markets. With its...
Medtronic posted a 9.4% YoY increase in profit to $1.02 bln, or $0.74 per share, for the first quarter of 2018. The company generated most of its...
At an AIDS conference in Paris on July 24, 2017, Johnson&Johnson announced updates on its developmental AIDS drug. And guess what, it's good news!
At the 9th IAS Conference on HIV Science, JNJ announced results of its clinical trials on AIDS vaccine. And guess what? It's good news. This is huge!
Is this deal advantageous for Celgene? BeiGene (ADR) has surged nearly 28% as of now.
